SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines

X Li, Z Mi, Z Liu, P Rong - Frontiers in Microbiology, 2024 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), emerged in December 2019 with staggering economic fallout …

[HTML][HTML] SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

AA Rabaan, SH Al-Ahmed, R Sah, R Tiwari… - Annals of Clinical …, 2020 - Springer
A novel coronavirus (SARS-CoV-2), causing an emerging coronavirus disease (COVID-19),
first detected in Wuhan City, Hubei Province, China, which has taken a catastrophic turn with …

Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2/COVID-19 pandemic

SB Barbuddhe, DB Rawool, PP Gaonkar… - Human Vaccines & …, 2020 - Taylor & Francis
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), the etiological agent of
the novel coronavirus disease (COVID-19), has posed a great public health threat to the …

SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies

A Salimi-Jeda, S Abbassi, A Mousavizadeh… - International …, 2021 - Elsevier
More than a year after the SARS-CoV-2 pandemic, the Coronavirus disease 19 (COVID-19)
is still a major global challenge for scientists to understand the different dimensions of …

[HTML][HTML] Advances in pathogenesis, progression, potential targets and targeted therapeutic strategies in SARS-CoV-2-Induced COVID-19

H Zhou, WJ Ni, W Huang, Z Wang, M Cai… - Frontiers in …, 2022 - frontiersin.org
As the new year of 2020 approaches, an acute respiratory disease quietly caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus …

[HTML][HTML] An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines

DS Mathew, T Pandya, H Pandya, Y Vaghela… - Biomolecules, 2023 - mdpi.com
The Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has significantly impacted the health and …

[HTML][HTML] COVID-19: unmasking emerging SARS-CoV-2 variants, vaccines and therapeutic strategies

R Raman, KJ Patel, K Ranjan - Biomolecules, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major …

Recent Advances in Understanding SARS-CoV-2 Infection and Updates on Potential Diagnostic and Therapeutics for COVID-19

D Verma, AK Yadav, N Chaudhary… - …, 2022 - ingentaconnect.com
A more focused approach is needed to understand the SARS-CoV-2 virulence, structure,
and genomics to devise more effective diagnostic and treatment interventions as this virus …

[HTML][HTML] Translational approaches to combat emerging viral infections: diagnosis, immunopathogenesis, and therapeutics

GP Sreekanth, GN Malavige - Frontiers in Cellular and Infection …, 2024 - frontiersin.org
Several novel viral infections have caused global outbreaks in the past. However, the recent
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) developed as a pandemic …

SARS-CoV-2: Pathogenic mechanisms and host immune response

H Yasmin, S Saha, MT Butt, RK Modi… - … : Infection and Immunity, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-
sense RNA coronavirus responsible for the COVID-19 pandemic. Since December 2019 …